Details of the Drug Reposition

General Information of This Drug (ID: DM5E9LX)

• Drug Name: GSK586529 (DM5E9LX)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Depression	DIS3XJ69	6A70-6A7Z	Phase 1	[1]
Anxiety disorder	DISBI2BT	6B00-6B0Z	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT00703547) A First Time in Human Study of GSK586529 in Healthy Volunteers. U.S. National Institutes of Health.